Involvement of the niacin receptor GPR109a in the local control of glucose uptake in small intestine of type 2 diabetic mice

Nutrients

Volumn 7, Issue 9, 2015, Pages 7543-7561

  Wong, Tung Po ^a   Chan, Leo Ka Yu ^a   Leung, Po Sing ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Caco 2; Enterocytes; Glucose transport; GLUT2; Hyperglycemia; Hyperlipidemia; Jejunum; SGLT1

Indexed keywords

MESSENGER RNA; NICOTINIC ACID; G PROTEIN COUPLED RECEPTOR; GLUCOSE BLOOD LEVEL; HCAR2 PROTEIN, HUMAN; HCAR2 PROTEIN, MOUSE; NICOTINIC RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; GENETIC TRANSFECTION; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HYPERGLYCEMIA; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; LIQUID SCINTILLATION COUNTING; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; AGONISTS; ANIMAL; BLOOD; CACO-2 CELL LINE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; INTESTINE ABSORPTION; INTESTINE CELL; JEJUNUM; METABOLISM; RNA INTERFERENCE; UPREGULATION;

ANIMALS; BLOOD GLUCOSE; CACO-2 CELLS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROCYTES; HUMANS; INTESTINAL ABSORPTION; JEJUNUM; MALE; NIACIN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC; RNA INTERFERENCE; RNA, MESSENGER; TRANSFECTION; UP-REGULATION;

EID: 84941204364     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7095352     Document Type: Article

References (46)

1. Sprafka, J.M.; Burke, G.L.; Folsom, A.R.; McGovern, P.G.; Hahn, L.P. Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey. Diabetes Care 1991, 14, 537-543. [CrossRef]
2. Haffner, S.M.; Lehto, S.; Rönnemaa, T.; Pyörälä, K.; Laakso, M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 1998, 339, 229-234. [CrossRef]
3. Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285, 2486-2497.
4. Guyton, J.R.; Goldberg, A.C.; Kreisberg, R.A.; Sprecher, D.L.; Superko, H.R.; O'Connor, C.M. Effectiveness of once-nightly dosing of extended release niacin alone and in combination for hypercholesterolemia. Am. J. Cardiol. 1998, 82, 737-743. [CrossRef]
5. Phan, B.A.; Muñoz, L.; Shadzi, P.; Isquith, D.; Triller, M.; Brown, B.G.; Zhao, X.Q. Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (<100 mg/dL): A combined analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition by MRI during lipid-lowering (CPC) study. Am. J. Cardiol. 2013, 111, 352-355.
6. Hochholzer, W.; Berg, D.D.; Giugliano, R.P. The facts behind niacin. Ther. Adv. Cardiovasc. Dis. 2011, 5, 227-240. [CrossRef]
7. Mcgovern, M.E. Use of nicotinic acid in patients with elevated fasting glucose, diabetes, or metabolic syndrome. Br. J. Diabetes Vasc. Dis. 2004, 4, 78. [CrossRef]
8. Victoria, C.R.; Meneghelli, U.G. Kinetics of jejunal glucose transport in niacin deficient rats. Arq. Gastroenterol. 1990, 27, 191-196.
9. Victoria, C.R. Jejunal electrogenic transport of glucose in rats with niacin deficiency. Arq. Gastroenterol. 1994, 31, 18-23.
10. Chen, L.; So, W.Y.; Li, Y.T.; Cheng, Q.; Boucher, B.J.; Leung, P.S. Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets. Mol. Cell. Endocrinol. 2015, 404, 56-66. [CrossRef]
11. Soga, T.; Kamohara, M.; Takasaki, J.; Matsumoto, S.; Saito, T.; Ohishi, T.; Hiyama, H.; Matsuo, A.; Matsushime, H.; Furuichi, K. Molecular identification of nicotinic acid receptor. Biochem. Biophys. Res. Commun. 2003, 303, 364-369. [CrossRef]
12. Tunaru, S.; Kero, J.; Schaub, A.; Wufka, C.; Blaukat, A.; Pfeffer, K.; Offermanns, S. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat. Med. 2003, 9, 352-355. [CrossRef]
13. Wise, A.; Foord, S.M.; Fraser, N.J.; Barnes, A.A.; Elshourbagy, N.; Eilert, M.; Ignar, D.M.; Murdock, P.R.; Steplewski, K.; Green, A.; et al. Molecular identification of high and low affinity receptors for nicotinic acid. J. Biol. Chem. 2003, 278, 9869-9874. [CrossRef]
14. Offermanns, S. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target. Trends Pharmacol. Sci. 2006, 7, 384-390. [CrossRef]
15. Zellner, C.; Pullinger, C.R.; Aouizerat, B.E.; Frost, P.H.; Kwok, P.Y.; Malloy, M.J.; Kane, J.P. Variations in human HM74 (GPR109B) and HM74A (GPR109A) niacin receptors. Hum. Mutat. 2005, 25, 18-21. [CrossRef]
16. Cresci, G.A.; Thangaraju, M.; Mellinger, J.D.; Liu, K.; Ganapathy, V. Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8. J. Gastrointest. Surg. 2010, 14, 449-461. [CrossRef]
17. Sharp, P.A.; Boyer, S.; Srai, S.K.; Baldwin, S.A.; Debnam, E.S. Early diabetes-induced changes in rat jejunal glucose transport and the response to insulin. J. Endocrinol. 1997, 154, 19-25. [CrossRef]
18. Kellett, G.L.; Helliwell, P.A. The diffusive component of intestinal glucose absorption is mediated by the glucose-induced recruitment of GLUT2 to the brush-border membrane. Biochem. J. 2000, 350, 155-162. [CrossRef]
19. Kellett, G.L. The facilitated component of intestinal glucose absorption. J. Physiol. 2001, 531, 585-595. [CrossRef]
20. Tobin, V.; le Gall, M.; Fioramonti, X.; Stolarczyk, E.; Blazquez, A.G.; Klein, C.; Prigent, M.; Serradas, P.; Cuif, M.H.; Magnan, C.; et al. Insulin internalizes GLUT2 in the enterocytes of healthy but not insulin-resistant mice. Diabetes 2008, 57, 55-62. [CrossRef]
21. Kellett, G.L.; Brot-Laroche, E. Apical GLUT2: A major pathway of intestinal sugar absorption. Diabetes 2005, 54, 3056-3062. [CrossRef]
22. Del Castillo, J.R. The use of hyperosmolar, intracellular-like solutions for the isolation of epithelial cells from guinea-pig small intestine. Biochim. Biophys. Acta 1987, 901, 201-208. [CrossRef]
23. Wong, T.P.; Debnam, E.S.; Leung, P.S. Involvement of an enterocyte renin-angiotensin system in the local control of SGLT1-dependent glucose uptake across the rat small intestinal brush border membrane. J. Physiol. 2007, 584, 613-623. [CrossRef]
24. Wong, T.P.; Debnam, E.S.; Leung, P.S. Diabetes mellitus and expression of the enterocyte renin-angiotensin system: Implications for control of glucose transport across the brush border membrane. Am. J. Physiol. Cell Physiol. 2009, 297, 601-610. [CrossRef]
25. Ip, S.P.; Wong, T.P.; Tsai, S.J.; Leung, P.S. The recovery of some components of the renin angiotensin system in the rat pancreas after chronic exposure to hypoxic condition. J. Mol. Endocrinol. 2003, 3, 563-571. [CrossRef]
26. Chu, K.Y.; Leung, P.S. Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet β-cell function in young Type 2 diabetic mice. Antioxid. Redox. Signal. 2007, 9, 869-878. [CrossRef]
27. Lau, T.; Carlsson, P.O.; Leung, P.S. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 2004, 47, 240-248. [CrossRef]
28. Debnam, E.S.; Smith, M.W.; Sharp, P.A.; Srai, S.K.; Turvey, A.; Keable, S.J. The effects of streptozotocin diabetes on sodium-glucose transporter (SGLT1) expression and function in rat jejunal and ileal villus-attached enterocytes. Pflugers 1995, 430, 151-159. [CrossRef]
29. Karasov, W.H.; Pond, R.S.; Solberg, D.H.; Diamond, J.M. Regulation of proline and glucose transport in mouse intestine by dietary substrate levels. Proc. Natl. Acad. Sci. USA 1983, 80, 7674-7677. [CrossRef]
30. Gilbert, T.; Rodriguez-Boulan, E. Induction of vacuolar apical compartments in the Caco-2 intestinal epithelial cell line. J. Cell Sci. 1991, 100, 451-458.
31. Jumarie, C.; Malo, C. Caco-2 cells cultured in serum-free medium as a model for the study of enterocytic differentiation in vitro. J. Cell Physiol. 1991, 149, 24-33. [CrossRef]
32. Gambhir, D.; Ananth, S.; Veeranan-Karmegam, R.; Elangovan, S.; Hester, S.; Jennings, E.; Offermanns, S.; Nussbaum, J.J.; Smith, S.B.; Thangaraju, M.; et al. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2012, 53, 2208-2217. [CrossRef]
33. Singh, N.; Gurav, A.; Sivaprakasam, S.; Brady, E.; Padia, R.; Shi, H.; Thangaraju, M.; Prasad, P.D.; Manicassamy, S.; Munn, D.H.; et al. Activation of GPR109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014, 40, 128-139. [CrossRef]
34. Chai, J.T.; Digby, J.E.; Choudhury, R.P. GPR109A and Vascular inflammation. Curr. Atheroscler. Rep. 2013, 15, 325. [CrossRef]
35. Wong, T.P.; Ho, K.Y.; Ng, E.K.W.; Debnam, E.S.; Leung, P.S. Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: Implications for glucose transport. Am. J. Physiol. Endocrinol. 2012, 303, E669-E681. [CrossRef]
36. Bechgaard, H.; Jespersen, S. GI absorption of niacin in humans. J. Pharm. Sci. 1977, 66, 871-872. [CrossRef]
37. Johnson, R.L.; Ghishan, F.K.; Kaunitz, J.D.; Merchant, J.L.; Said, H.M.; Wood, J.D. Physiology of the Gastrointestinal Tract, 5th ed.; Elsevier Inc.: San Diego, CA, USA, 2012; Volume 2.
38. Taylor, W.M.; Mak, M.L.; Halperin, M.L. Effect of 3ʹ,5ʹ-cyclic AMP on glucose transport in rat adipocytes. Proc. Natl. Acad. Sci. USA 1976, 73, 4359-4363. [CrossRef]
39. Taylor, W.M.; Halperin, M.L. Stimulation of glucose transport in rat adipocytes by insulin, adenosine, nicotinic acid and hydrogen peroxide. Role of adenosine 3ʹ,5ʹ-cyclic monophosphate. Biochem. J. 1979, 178, 381-389. [CrossRef]
40. Stümpel, F.; Scholtka, B.; Jungermann, K. A new role for enteric glucagon-37: Acute stimulation of glucose absorption in rat small intestine. FEBS Lett. 1997, 410, 515-519. [CrossRef]
41. Lee, W.Y.; Loflin, P.; Clancey, C.J.; Peng, H.; Lever, J.E. Cyclic nucleotide regulation of Na+/glucose cotransporter (SGLT1) mRNA stability. Interaction of a nucleocytoplasmic protein with a regulatory domain in the 3ʹ-untranslated region critical for stabilization. J. Biol. Chem. 2000, 275, 33998-34008. [CrossRef]
42. Rencurel, F.; Waeber, G.; Bonny, C.; Antoine, B.; Maulard, P.; Girard, J.; Leturque, A. cAMP prevents the glucose-mediated stimulation of GLUT2 gene transcription in hepatocytes. Biochem. J. 1997, 322, 441-448. [CrossRef]
43. Li, G.; Deng, X.; Wu, C.; Zhou, Q.; Chen, L.; Shi, Y.; Huang, H.; Zhou, N. Distinct kinetic and spatial patterns of protein kinase C (PKC)-and epidermal growth factor receptor (EGFR)-dependent activation of extracellular signal-regulated kinases 1 and 2 by human nicotinic acid receptor GPR109A. J. Biol. Chem. 2011, 286, 31199-31212. [CrossRef]
44. Cohen, M.; Kitsberg, D.; Tsytkin, S.; Shulman, M.; Aroeti, B.; Nahmias, Y. Live imaging of GLUT2 glucose dependent trafficking and its inhibition in polarized epithelial cysts. Open Biol. 2014, 4. [CrossRef]
45. Thorens, B.; Dériaz, N.; Bosco, D.; DeVos, A.; Pipeleers, D.; Schuit, F.; Meda, P.; Porret, A. Protein kinase A-dependent phosphorylation of GLUT2 in pancreatic β cells. J. Biol. Chem. 1996, 271, 8075-8081.
46. Wright, E.M.; Hirsch, J.R.; Loo, D.D.; Zampighi, G.A. Regulation of Na+/glucose cotransporters. J. Exp. Biol. 1997, 200, 287-293.